Typhoid Treatment: Study Detects Antibiotic Resistance

Chandigarh:  A recent study published in Chandigarh revealed concerning levels of typhoid fever. A significant finding was the increasing ineffectiveness of ciprofloxacin, a standard antibiotic used for typhoid treatment.

The causative organism, Salmonella Typhi, demonstrated total resistance to ciprofloxacin, presumably due to excessive antibiotic usage. Nevertheless, the bacteria remained treatable with ceftriaxone as an alternative option. The study attributed a possible cause of such resistance against the first line of drugs due to overuse of fluoroquinolones over the last decade.

The study ‘Incidence, antimicrobial susceptibility & out of pocket expenditure of severe enteric fever in Chandigarh, north India’ by Drs Madhu Gupta, Vikas Suri, Arun Bansal, Sadbhavna Pandit, Shankar Prinja et al from PGI, GMCH and GMSH-16 has been published in the ‘Indian Journal of Medical Research’. It was conducted on 1,600 patients which included 1,356 adults and 244 children.

The research indicated that 227 individuals per 1 lakh were diagnosed with typhoid, which aligned with global health statistics but remains worrying for the area. Researchers note that inadequate sanitary facilities in these semi-urban localities facilitate disease transmission, increasing the risk of infection through contaminated water and food sources.

Healthcare professionals express particular worry about increasing antibiotic resistance, which could complicate future treatment approaches. The investigation highlighted issues regarding out-of-pocket expenses (OOPE) for typhoid treatment. This cost burden is partially attributed to patients seeking care at private healthcare facilities, which often charge higher fees. Additionally, the research identified that easy access to non-prescription antibiotics contributes to elevated costs and antibiotic resistance issues.

The OOPE due to hospitalization of individuals infected with S. Paratyphi was Rs 8,696.6 was significantly higher than the individuals infected with S. Typhi (Rs 7309) and among cases who were hospitalised for more than seven days as compared with those with a stay of 3-7 days.

Healthcare specialists are advocating for swift intervention to tackle the typhoid situation in Chandigarh. A primary suggestion includes implementing the typhoid conjugate vaccine, which has demonstrated effectiveness in reducing illness and mortality rates.

Related Posts

  • Pharma
  • July 16, 2025
  • 148 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

  • Pharma
  • July 16, 2025
  • 48 views
Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

The pharma sector will be in focus on July 16, after Donald Trump said that pharmaceuticals tariffs would be implemented soon. Shares of pharmaceutical companies traded flat on Wednesday, July…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Famous Vaidyaratnam Ayurveda Clinic in Delhi is now more Accessible to Patients

Famous Vaidyaratnam  Ayurveda  Clinic in Delhi is now more Accessible to Patients